(Press-News.org) In a comparison of the angiotensin II receptor blockers (ARBs) candesartan and losartan, used by patients with heart failure, candesartan was associated with a lower risk of death at 1 and 5 years, according to a study in the January 12 issue of JAMA.
Angiotensin II receptor blockers reduce cardiovascular mortality and heart failure (HF) hospitalization in patients with HF with reduced left ventricular ejection fraction (LVEF; a measure of how well the left ventricle of the heart pumps with each contraction). Despite variable effects of different ARBs, they have not been tested head to head, and there are reasons to believe they may differ in efficacy, according to background information in the article. Previous research found that in elderly patients with HF, losartan was associated with higher mortality than other ARBs.
Maria Eklind-Cervenka, M.D., of the Department of Cardiology, South Hospital, Stockholm, and colleagues conducted a study to determine whether candesartan is associated with less all-cause mortality than losartan in patients with HF. The study included analysis of data from an HF registry (the Swedish Heart Failure Registry) of 30,254 patients registered from 62 hospitals and 60 outpatient clinics between 2000 and 2009. A total of 5,139 patients (average age, 74; 39 percent women) were treated with candesartan (n = 2,639) or losartan (n = 2,500).
In overall survival between the 2 groups, the researchers found that one-year survival was 90 percent for patients receiving candesartan and 83 percent for patients receiving losartan, and 5-year survival was 61 percent for patients receiving candesartan and 44 percent for patients receiving losartan. The results persisted in stratified analyses.
The researchers add that there are mechanistic reasons to believe candesartan may be more effective than losartan and that studies of candesartan have been larger and more conclusively positive than studies of losartan.
"In conclusion, our findings suggest that candesartan is associated with less all-cause mortality than losartan. However, clinical decision making should await supportive evidence of this observed association. Ideally, different ARB agents should be tested against each other in randomized controlled trials. It would also be important and perhaps more feasible to confirm our findings in other large HF registries," the authors write.
INFORMATION:
(JAMA. 2011;305[2]:175-182. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
To contact corresponding author Lars H. Lund, M.D., Ph.D., email lars.lund@alumni.duke.edu.
For More Information: Contact the JAMA/Archives Media Relations Department at 312-464-JAMA or email: mediarelations@jama-archives.org.
Comparison of medications for heart failure finds difference in risk of death
2011-01-12
ELSE PRESS RELEASES FROM THIS DATE:
For CABG, use of artery from arm does not appear to be superior to vein grafts from the leg
2011-01-12
Use of a radial artery (located within the forearm, wrist and hand) graft compared with a saphenous vein (from the leg) graft for coronary artery bypass grafting did not result in improved angiographic patency (the graft being open, unobstructed) one year after the procedure, according to a study in the January 12 issue of JAMA.
Coronary artery bypass grafting (CABG) is one of the most common operations performed, with a database indicating that in the United States, 163,048 patients had CABG surgery in 2008. The success of CABG depends on the long-term patency of the ...
Study finds more breaks from sitting are good for waistlines and hearts
2011-01-12
It is becoming well accepted that, as well as too little exercise, too much sitting is bad for people's health. Now a new study has found that it is not just the length of time people spend sitting down that can make a difference, but also the number of breaks that they take while sitting at their desk or on their sofa. Plenty of breaks, even if they are as little as one minute, seem to be good for people's hearts and their waistlines.
The study, which is published online today (Wednesday 12 January) in the European Heart Journal [1], is the first in a large, representative, ...
Acne bug could be the cause of your infections
2011-01-12
Previously, researchers thought the detection of P. acnes at the site of these infections was due to contamination from the skin. For example, an infection at a site within the body after surgery, could have been caused by bacteria transferred to an open wound from the skin during an operation. But recent research has contradicted this, suggesting P. acnes already within the body, may be the cause. Although it is often disregarded as a harmless bystander when found in blood and tissue swabs taken from patients, we should not rule out this bug in the diagnosis of disease.
People ...
New method for reporting solar data
2011-01-12
Washington, D.C. (January 11, 2011) -- A straightforward new way to calculate, compile, and graphically present solar radiation measurements in a format that is accessible to decision makers and the general public has been developed by researchers at the University of Texas at Austin.
The method presents solar data in a framework that "can be used by policymakers, businesses, and the public to understand the magnitude of solar resources in a given region, which might aid consumers in selecting solar technologies, or policymakers in designing solar policies," says David ...
Trapped sunlight cleans water
2011-01-12
Washington, D.C. (January 11, 2011) -- High energy costs are one drawback of making clean water from waste effluents. According to an article in the journal Biomicrofluidics, which is published by the American Institute of Physics, a new system that combines two different technologies proposes to break down contaminants using the cheapest possible energy source, sunlight. Microfluidics – transporting water through tiny channels -- and photocatalysis -- using light to break down impurities – come together in the science of optofluidics.
"These two technologies have been ...
Off-the-shelf electronics turn up gain on spectroscopy
2011-01-12
Washington, D.C. (January 11, 2011) -- Whether the object of attention is a novel aspect of the universe or an enigmatic and distant colleague, listening is key to nearly any effort to seek understanding. And not just with your ears. Spectroscopy, the study of how atoms absorb and emit electromagnetic radiation, is like listening, too. The technique is central to a range of physics experiments and can be thought of as an attempt to filter out useful information from what various sensors and detectors often first "hear" as undifferentiated electromagnetic noise.
Now, ...
New research aims to shut down viral assembly line
2011-01-12
Under the electron microscope, a coronavirus may resemble a spiny sea urchin or appear crownlike, (the shape from which this family of pathogens takes its name). Previously recognized as the second leading cause of the common cold in humans and for economically important diseases in many domesticated animals, a new disease form abruptly emerged as a major public health concern in 2002, when the SARS coronavirus (CoV) surfaced in Asia.
The rapid spread of the virus caused significant social and economic disruption worldwide , infecting over 8000 people with Sudden Acute ...
New MS target identified by Canadian researchers
2011-01-12
Multiple sclerosis (MS) is a disease caused by damage to myelin – the protective covering wrapped around the nerves of the central nervous system (CNS).
Previous studies have shown that certain white blood (immune) cells, called leukocytes, infiltrate the CNS and play a significant role in causing the damage that contributes to MS symptoms. It has also been shown that these leukocytes enter the CNS with help from a family of molecules called MMPs.
Using a mouse model, researchers have discovered that a molecular switch called EMMPRIN plays an important role in MS. The ...
Cell Transplantation reports a success in treating end-stage liver disease
2011-01-12
Tampa, Fla. (Jan. 10, 2011) – Transplanting their own (autologous) bone marrow-derived stem cells into 48 patients with end-stage liver disease resulted in therapeutic benefit to a high number of the patients, report researchers publishing in the current issue of Cell Transplantation (19:11). Yet, the mechanism by which the infusion of CD34+ stem cells improves liver function remains elusive, they say.
The study, carried out by a team of researchers in California and in Egypt, is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/.
According ...
International first: Gas-phase carbonic acid isolated
2011-01-12
A team of chemists headed by Thomas Loerting from the University of Innsbruck and Hinrich Grothe from the Vienna University of Technology (TU Wien) in Austria have prepared and isolated gas-phase carbonic acid and have succeeded in characterizing the gas-phase molecules by using infrared spectroscopy. The results were published in the journal Angewandte Chemie International Edition.
In textbooks and other media the widespread belief still prevails that stable carbonic acid cannot be produced in pure form and is practically non-existent as it immediately decomposes to ...